Official answer: Yes, treatment with Paxlovid’s active ingredient, nirmatrelvir, showed a reduced risk of long COVID, according to...
PAXLOVID™ (PF-07321332; ritonavir)was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adults with COVID-19 In the overall study population through Day 28, no deaths were reported in patients who receivedPAXLOVID™as compared to...
Official answer: A study looked at how long do COVID-19 symptoms last showed that: Most people's COVID-19 symptoms last between 13...
We need to wait for more trials to be completed to find out if Tamiflu reduces the length of illness, complications, and the death rate in COVID-19 patients. The study will also be looking for any side effects or any unexpected issues that Tamiflu may cause in COVID-19 patients. ...
Paxlovid needs to be started within 5 days of your symptom onset. This medicine may help to keep you put of the hospital and might be life-saving, so do not hesitate to contact your doctor. Your doctor may also select additional or different treatments for you. There’s other recommended...